Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Inhibits human amidolytic and kininogenase activities of tissue kallikrein. Additionally we are shipping serpin Peptidase Inhibitor, Clade A (Alpha-1 Antiproteinase, Antitrypsin), Member 4 Kits (19) and serpin Peptidase Inhibitor, Clade A (Alpha-1 Antiproteinase, Antitrypsin), Member 4 Proteins (6) and many more products for this protein.
Showing 10 out of 65 products:
KBP reduces expression of VEGF (show VEGFA Antibodies) and HIF-1alpha (show HIF1A Antibodies) nuclear translocation
generated a meta-marker model made up of SERPINA4 and PON1 (show PON1 Antibodies) that is useful as a differential diagnostic biomarker differentiating lung cancer from other lung diseases.
Our results indicate that during severe sepsis and septic shock, a decrease in plasma concentrations of kallistatin reflects increased severity and poorer outcome of disease.
data suggest that overexpression of kallistatin interferes with lymphopoiesis, ultimately impacting the level of circulating CD19 (show CD19 Antibodies)(+) B lymphocytes.
Kallistatin levels were correlated with some markers of systemic inflammation in the HIV population.
Increased kallistatin levels in type 1 diabetes and its relation with carotid intima media thickness may reflect vascular dysfunction and suggest a link between micro- and macro-angiopathy.
reveal novel mechanisms of kallistatin in inducing apoptosis and autophagy in breast cancer cells
crystal structure of kallistatin 1.9 A resolution
Kallistatin protects against renal ischemia-reperfusion injury by blocking oxidative stress and renal inflammation.
Kallistatin's heparin-binding site is crucial for preventing TGF-beta (show TGFB1 Antibodies)-induced miR (show MLXIP Antibodies)-21 and oxidative stress, while its active site is key for stimulating the expression of eNOS (show NOS3 Antibodies).
Plasma kallistatin is a novel marker for severe community-acquired pneumonia prognosis.
Inhibits human amidolytic and kininogenase activities of tissue kallikrein. Inhibition is achieved by formation of an equimolar, heat- and SDS-stable complex between the inhibitor and the enzyme, and generation of a small C-terminal fragment of the inhibitor due to cleavage at the reactive site by tissue kallikrein.
serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4
, serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4
, kallikrein inhibitor
, peptidase inhibitor 4
, protease inhibitor 4 (kallistatin)
, serpin A4